The generic drug maker started with cheeky ads selling knockoff Viagra. Now it’s trying to fend off big drugmakers and navigate a critical government ruling to defend a high-growth line of revenue. Jay Ritter comments on how Hims’ SPAC has
Faculty & Research: page 1
Read the latest news and research from University of Florida Warrington College of Business faculty, who are thought leaders in their respective fields and provide expert guidance in the classroom. Their research provides industry leaders and individuals with insights they can use in their careers and daily lives.
Page:
Business Insider | Despite tariffs reversal, bankers say the IPO market is still on ice
Jay Ritter shares his insights for these stories on the impact of tariffs on the IPO market. Read more from Business Insider and Triangle Business Journal. Despite tariffs reversal, bankers say the IPO market is still on ice – Business
Charities spend big to defend their board’s corporate agendas, research finds
Charities with corporate leaders on their boards spend an average of $130,000 a year lobbying on behalf of their connected companies. That’s according to a first-of-its-kind study from Assistant Professor Sehoon Kim and Eugene F. Brigham Chair in Finance Joel
Business Insider | The IPO comeback is stalling out, thanks to Trump’s tariffs
On Friday, StubHub and Klarna both announced they were putting off their planned IPOs, as Donald Trump’s tariffs sparked a huge slide in the stock market. IPO analysts at Renaissance now estimate that there could be as few as 150
ABC News | Shares in Trump social media company sink following concerns about insider selloff
Shares in Donald Trump’s social media company sank in morning trading on Wednesday, a day after the company filed paperwork with the Securities and Exchange Commission that could allow the president’s trust to sell more than $2 billion of shares. The
Barron’s | What CoreWeave stock’s trading means for the IPO market
The market for initial public markets has basically been frozen for three years. And CoreWeave’s recent IPO has done nothing to change the dynamic, suggesting 2025 could be another IPO bust. There hasn’t been a good market for IPOs since 2021, when
CNBC | Nvidia-backed CoreWeave closes flat at $40 after biggest U.S. tech IPO since 2021
The offering has captured the attention of investors from Wall Street to Silicon Valley, as CoreWeave represents the first pure-play AI IPO and the largest tech debut in the U.S. in four years. The IPO market has been largely shut
Barron’s | CoreWeave Debuts: A Big IPO in a Slow Year
CoreWeave, a hotly anticipated initial public offering, priced on Thursday below its range, at $40 a share for a valuation of $23 billion, raising some $1.5 billion, well below earlier expectations. Jay Ritter shares his insight on the debut in
Is AI the new research scientist? Not so, according to a human-led study.
In a comprehensive study examining the capabilities of artificial intelligence in academic research, University of Florida researchers have found that while AI can be a valuable assistant, it falls short of replacing human scientists in many critical areas. The research,
Tampa Bay Times | Here’s how the U.S. can work with Bitcoin and blockchain for consumers
Widely misunderstood, blockchain technology and cryptoassets are often wrongly associated with anarchy and upheaval, explains Associate Professor Fahad Saleh in this column from the Tampa Bay Times.
Page: